Overview

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.
Phase:
PHASE3
Details
Lead Sponsor:
Kafrelsheikh University
Collaborator:
El-Sahel Teaching Hospital
Treatments:
Aspirin
Cilostazol
Ticagrelor